Skip to main content

Day: May 9, 2022

RGC Resources, Inc. Reschedules Second Quarter 2022 Earnings Call

ROANOKE, Va., May 09, 2022 (GLOBE NEWSWIRE) — RGC Resources, Inc. (NASDAQ: RGCO) will host its rescheduled quarterly conference call and webcast to review the results of its fiscal second quarter on Wednesday, May 11, 2022 at 9:00 a.m. eastern time. Related presentation materials are available before the call on the Company website on the Investor & Financial Information page at https://www.rgcresources.com/investor-financial-information/. The call has been rescheduled due to technical difficulties encountered in the originally scheduled call. Interested parties may access the conference call by dialing toll-free 1-866-705-2554 and entering conference identification number 917621. An archive of the webcast will be available for one year on the website at https://www.rgcresources.com/investor-financial-information/. RGC Resources,...

Continue reading

Tauriga Sciences Inc. Chief Executive Officer Completes 1,500,000 Share Insider Purchase

New York, NY, May 09, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences and Pharmaceutical Development Company, today announced that its Chief Executive Officer, Seth M. Shaw, completed an insider purchase for 1,500,000 shares of Tauriga Sciences Inc. common stock (quoted on the OTCQB – symbol: “TAUG”).  This Insider Purchase was completed between the dates of May 5-9, 2022 and a corresponding Form 4 will be filed this week.   E-Commerce Website:  www.taurigum.com ABOUT TAURIGA SCIENCES INC. Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives. The company manufactures and distributes several proprietary retail products...

Continue reading

Fagron shareholders approve all voting items AGM and EGM

Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 9 May 2022 Fagron shareholders approve all voting items AGM and EGM Today, Fagron held its annual general meeting of shareholders (AGM) and extraordinary general meeting of shareholders (EGM). The AGM and the EGM approved all voting items. The AGM approved, amongst other things, Fagron’s 2021 financial statements and the gross dividend of €0.20 per share over 2021. Also, Vera Bakker, Ann Desender, and Neeraj Sharma were appointed as independent and non-executive directors, and Management Deprez BV, represented by Veerle Deprez, was reappointed as independent and non-executive director, each for a four-year term. Rafael Padilla and Karin de Jong were reappointed as executive directors, also each for a four-year term. Other voting items approved by the AGM include Fagron’s...

Continue reading

Natural Gas Services Group, Inc. Reports First Quarter 2022 Financial and Operating Results

Midland, TX, May 09, 2022 (GLOBE NEWSWIRE) — Natural Gas Services Group, Inc. (NYSE:NGS), a leading provider of gas compression equipment and services to the natural gas industry, announces the following conference call information for their first quarter 2022 earnings release: Earnings Release: Monday, May 16, 2022 after market closesPublic distribution will be through Intrado Digital Media and the Natural Gas Services Group, Inc. website at www.ngsgi.com. Conference Call: Tuesday, May 17, 2022 at 10:00 a.m. Central, 11:00 a.m. EasternLive via phone by dialing 877-358-7306, pass code “Natural Gas Services”. All attendees and participants to the conference call should arrange to call in at least 5 minutes prior to the start time. Conference Call Replay For those unable to attend the live teleconference, a Webcast replay...

Continue reading

Nokia Corporation: Repurchase of own shares on 09.05.2022

Nokia CorporationStock Exchange Release9 May 2022 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 09.05.2022 Espoo, Finland – On 9 May 2022 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 316,425 4.65CEUX 13,117 4.63AQEU 8,101 4.69TQEX 11,357 4.66Total 349,000 4.65* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014...

Continue reading

DELTA AIR LINES AND AEROMEXICO CELEBRATE 5 YEARS OF THEIR U.S.-MEXICO TRANSBORDER ALLIANCE

Mexico City, May 09, 2022 (GLOBE NEWSWIRE) — DELTA AIR LINES AND AEROMEXICO CELEBRATE 5 YEARS OF THEIR U.S.-MEXICO TRANSBORDER ALLIANCESince the start of the Joint Cooperation Agreement in May 2017, the airlines have flown more than 28 million customers and operated 250,000 flights between the U.S. and Mexico. In May 2022, the partners will operate more than 4,300 flights, a 96% recovery compared to the same period in 2019.MEXICO CITY, May 9, 2022 – This May marks the five year anniversary of the implementation of Delta Air Lines and Aeromexico’s leading Joint Cooperation Agreement (JCA). The JCA is a transborder alliance that connects the carriers’ networks between the U.S. and Mexico and has improved service, expanded routes and benefited more than 28 million customers since launching in 2017. Throughout their JCA...

Continue reading

BBS publishes EU growth prospectus in connection to its EUR 4.5 million rights issue

Company Announcement, Insider information May 9th 2022 21:05 (CEST) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN PART, DIRECTLY OR INDIRECTLY, IN THE USA, AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION IS UNLAWFUL. With reference to the company announcement on 6 May 2022, the Board of Directors of BBS-Bioactive Bone Substitutes Plc (“BBS” or the “Company”) has on 6 May 2022 decided to arrange a rights issue totaling approximately EUR 4.5 million (the “Offering”) with two series of additional warrants (the “Warrants”) based on authorization granted by the Extraordinary General Meeting on 17 March 2022. The Offering consists of a maximum of approximately 3,490,762 new shares (the “Offer...

Continue reading

Proactive headlines including Pure Gold Mining, Plant-Based Investment, Love Pharma, i-80 Gold and CareRx Corporation

New York, May 09, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:Pure Gold Mining arranges non-brokered private placement of 200 million units for aggregate gross proceeds of $30M click here Plant-Based Investment agrees to purchase its management service provider for C$1.4 million click here Love Pharma completes second tranche of non-brokered private placement to raise gross proceeds of $47,500 click here i-80 Gold says key land acquisition will expand Granite Creek Property click here XPhyto reports positive results from Rotigotine study of two potential drug formulations click here Mednow confirms that its common shares are now trading on the OTCQX Best Market in the US click here CareRx Corporation releases...

Continue reading

Total number of shares and voting rights at April 30, 2022

9 May 2022 Orange: information on the total number of shares and voting rights referred to in Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers. In application of Article L. 22-10-46 of the French Commercial Code (Code de commerce), as from 3 April 2016, a double voting right is automatically granted to fully paid-up shares that have been held in registered form and under a single shareholder name for at least two years.Date Number of shares Number of treasury shares without voting rights Theoretical number of voting rights [1] Number of voting rights exercisable01/31/2022 2, 660, 056,599 2, 029,500 3, 104, 132,809 3, 102, 103,30902/28/2022 2, 660, 056,599 2, 234,500 3, 104, 094,376 3, 101, 859,87603/31/2022 2, 660, 056,599 1, 373,253 3,...

Continue reading

Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH

PARIS, May 09, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly targeting the brain to treat hypertension and heart failure, announces today that it has recruited all planned patients in its phase III pivotal study FRESH, which aims to evaluate firibastat’s efficacy in the treatment of difficult-to-treat1 and resistant2 hypertension. “We’re delighted to have completed recruitment in this study, which is the first step in our phase III program on difficult-to-treat and resistant hypertension, despite the challenges posed by the health crisis,” Jean-Philippe Milon, CEO of Quantum Genomics, announced. Eligible patients with difficult-to-treat or resistant hypertension have been randomized in 69 hospitals...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.